Bioceres Crop Solutions Corp. (NASDAQ:BIOX – Get Free Report) was the target of a significant growth in short interest during the month of September. As of September 30th, there was short interest totalling 611,100 shares, a growth of 26.9% from the September 15th total of 481,700 shares. Approximately 2.0% of the company’s stock are short sold. Based on an average daily volume of 110,100 shares, the days-to-cover ratio is currently 5.6 days.
Bioceres Crop Solutions Price Performance
NASDAQ:BIOX traded up $0.06 during trading hours on Friday, reaching $7.51. 130,720 shares of the company traded hands, compared to its average volume of 77,111. The firm’s 50-day moving average is $9.19 and its 200-day moving average is $10.71. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.28 and a quick ratio of 0.91. The stock has a market cap of $471.61 million, a P/E ratio of 751.00 and a beta of 0.47. Bioceres Crop Solutions has a 1-year low of $7.35 and a 1-year high of $14.05.
Bioceres Crop Solutions (NASDAQ:BIOX – Get Free Report) last posted its quarterly earnings data on Monday, September 9th. The company reported ($0.03) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.20 by ($0.23). Bioceres Crop Solutions had a return on equity of 0.93% and a net margin of 0.68%. The business had revenue of $124.30 million for the quarter, compared to analysts’ expectations of $126.75 million. During the same quarter in the prior year, the firm earned ($0.06) earnings per share. Equities research analysts expect that Bioceres Crop Solutions will post 0.39 earnings per share for the current fiscal year.
Institutional Trading of Bioceres Crop Solutions
Wall Street Analyst Weigh In
A number of research analysts recently issued reports on the stock. Lake Street Capital decreased their target price on shares of Bioceres Crop Solutions from $25.00 to $13.00 and set a “buy” rating for the company in a research report on Wednesday, September 11th. Canaccord Genuity Group decreased their target price on shares of Bioceres Crop Solutions from $17.00 to $12.50 and set a “buy” rating for the company in a research note on Wednesday, September 11th. Oppenheimer reduced their price target on Bioceres Crop Solutions from $17.00 to $16.00 and set an “outperform” rating for the company in a report on Wednesday, September 11th. Canaccord Genuity Group raised Bioceres Crop Solutions to a “strong-buy” rating in a report on Friday, July 19th. Finally, Roth Capital raised shares of Bioceres Crop Solutions to a “strong-buy” rating in a report on Tuesday, July 2nd. Four analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Buy” and a consensus price target of $13.63.
View Our Latest Analysis on Bioceres Crop Solutions
Bioceres Crop Solutions Company Profile
Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.
Read More
- Five stocks we like better than Bioceres Crop Solutions
- Top Stocks Investing in 5G Technology
- Why Fastenal Stock Could Hit New Highs After Strong Q3 Results
- Where Do I Find 52-Week Highs and Lows?
- Why Eli Lilly Stock Is Soaring—and How It Plans to Stay on Top
- Insider Trades May Not Tell You What You Think
- 3 Mid-Cap Stocks Under $20 With Insider Buying and Major Upside
Receive News & Ratings for Bioceres Crop Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioceres Crop Solutions and related companies with MarketBeat.com's FREE daily email newsletter.